Let's also remember, none of the big pharma players are in the canaloplasty MIGS space.
In 2016, Allergen bought stent company/procedure Aquesys for $300m. Alcon bought Ivantus (mad ethe Hydrus stent) for $475m.
These purchases gives some idea of the imbedded value of these procedures!
Nova Eye Medical (EYE) Discussion, page-6
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
-0.005(2.27%) |
Mkt cap ! $49.19M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 21.0¢ | $151.6K | 700.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 45496 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 34470 | 1 |
View Market Depth
| Last trade - 16.10pm 11/06/2024 (20 minute delay) ? |
|
|||||
|
Last
21.5¢ |
Change
-0.005 ( 4.06 %) |
||||
| Open | High | Low | Volume | ||
| 22.5¢ | 22.5¢ | 21.0¢ | 234945 | ||
| Last updated 15.59pm 11/06/2024 ? | |||||
| EYE (ASX) Chart |